Ellis Investment Partners’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,466
| Closed | -$314K | – | 240 |
|
|
2024
Q1 | $314K | Buy |
+3,466
| New | +$314K | 0.07% | 173 |
|
|
2022
Q4 | – | Sell |
-265
| Closed | -$17K | – | 597 |
|
|
2022
Q3 | $17K | Hold |
265
| – | – | ﹤0.01% | 508 |
|
|
2022
Q2 | $20K | Hold |
265
| – | – | 0.01% | 506 |
|
|
2022
Q1 | $21K | Hold |
265
| – | – | 0.01% | 519 |
|
|
2021
Q4 | $20K | Hold |
265
| – | – | ﹤0.01% | 537 |
|
|
2021
Q3 | $19K | Hold |
265
| – | – | ﹤0.01% | 519 |
|
|
2021
Q2 | $19K | Buy |
265
+1
| +0.4% | +$72 | ﹤0.01% | 520 |
|
|
2021
Q1 | $18K | Buy |
264
+1
| +0.4% | +$68 | 0.01% | 508 |
|
|
2020
Q4 | $18K | Buy |
263
+1
| +0.4% | +$68 | 0.01% | 494 |
|
|
2020
Q3 | $16K | Buy |
262
+1
| +0.4% | +$61 | 0.01% | 499 |
|
|
2020
Q2 | $16K | Buy |
261
+2
| +0.8% | +$123 | 0.01% | 481 |
|
|
2020
Q1 | $13K | Buy |
259
+1
| +0.4% | +$50 | 0.01% | 450 |
|
|
2019
Q4 | $16K | Buy |
258
+1
| +0.4% | +$62 | 0.01% | 465 |
|
|
2019
Q3 | $14K | Buy |
257
+1
| +0.4% | +$54 | 0.01% | 494 |
|
|
2019
Q2 | $15K | Buy |
+256
| New | +$15K | 0.01% | 478 |
|